Gilead Sciences (GILD) Stock Gains 20% YTD: What Lies Ahead?

Published on November 26, 2021

Gilead's (GILD) performance in the year has been pretty good on contribution from Veklury. The company is now focusing on its oncology business as the virology business faces challenges.

Continue reading on website
Other news

Snowflake (SNOW) to Report Q3 Earnings: What's in the Cards?

November 26, 2021
Snowflake's (SNOW) third-quarter fiscal 2022 results are likely to benefit from strong demand for the Data Cloud platform and expanded clientele.

Should You Buy Semtech (SMTC) Ahead of Earnings?

November 26, 2021
Semtech (SMTC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.